Uranium Explorer Expecting Drill Results Soon
Source: The Critical Investor  (1/16/22)
The Critical Investor discusses the latest developments for Blue Sky Uranium with CEO Niko Cacos, as a new drill program at Ivana has commenced, and the company has won a lawsuit. More >

BC Junior Looks to Boost Status in Golden Triangle
Source: Streetwise Reports  (1/15/22)
If your neighbors sell their house, the sale price will tell you a lot about the value of your home. In British Columbia’s Golden Triangle, companies with mines and well-defined resource development plans are getting taken out and the remaining players — and their investors — can see the favorable writing on the wall. More >

Semiconductor Sales Forecast Third Straight Year of Growth on Tight Supplies, Global Digital Transformation
Source: McAlinden Research  (1/15/22)
After semiconductor sales shattered records in 2021 amid an ongoing supply shortage, chip manufacturers are forecasting another year of growth in 2022. An overwhelming digital transformation is expected to ramp up this year across multiple industries, which could subsequently bring over half a trillion dollars to the semiconductor industry, writes McAlinden Research Partners. More >

Lithium Mining Co. Expands Asset Portfolio in New Deal
Source: The Critical Investor  (1/14/22)
The Critical Investor provides a quick update about Argentina Lithium, after they announced the acquisition of more lithium projects, on the back of a C$6M raise. All this when lithium product prices are breaking record after record. More >

Sell-Side Research Started On Copper Mining Co.
  (1/13/22)
World Copper continues to execute its strategy of acquiring and advancing copper projects, with lots of work planned for 2022, noted a Zacks Small-Cap Research report. More >

A Critical Q & A With Kenorland Minerals CEO Zach Flood
Source: The Critical Investor  (1/13/22)
After Kenorland Minerals announced its latest batch of drill results, the Critical Investor took the opportunity to do an extensive interview with CEO Zach Flood to discuss results, programs, strategy, and projects for 2022. More >

Leading Low-Cost Homebuilder Posts 71% Increase in Q4 EPS
Source: Streetwise Reports  (1/13/22)
Shares of leading homebuilder KB Home rose 16% after the company reported Q4/21 and FY/21 financial results that included substantial increases in revenues and margins fueled by rising sales prices and demand for new homes nationwide. More >

Successful Junior Miner Sees Cash Flow
Source: Michael Sheikh  (1/13/22)
Michael Sheikh explains what makes Guanajuato Silver Co. a unique opportunity and takes a look at five other companies that caught his eye. More >

Get Ballanger's Top Picks for 2022
Source: Michael Ballanger  (1/12/22)
Sector expert Michael Ballanger finds himself at an investing crossroads. Find out what his top picks are for 2022. More >

Goliath Nails High-Grade Gold in 24 Out of 24 Holes, Stock Declines
Source: Bob Moriarty  (1/12/22)
Bob Moriarty of 321Gold shares his thoughts on Goliath Resources' outstanding drill results, which they just announced on Tuesday. More >

Progress at Several Top Resource Companies
Source: Adrian Day  (1/12/22)
In this update, Adrian Day discusses some recent developments that occurred over the holidays, or otherwise got lost in the shuffle.
More >

Ph1 Trial Results of Dementia Drug Positive
  (1/12/22)
Anavex Life Sciences' study of Anavex 3-71 in frontotemporal dementia met primary and secondary safety endpoints, noted a Dawson James Securities report. More >

Cell Firm Joins With Food Co. to Create Meat Substitute
  (1/12/22)
Pluristem Therapeutics and Tnuva will incorporate a new company that will use its own funding and resources to develop cell-based synthetic meat products, noted a Dawson James Securities report. More >

Vaccine Maker Doses 1st Patient in Phase 1b Parkinson's Trial
Source: Streetwise Reports  (1/12/22)
Shares of new class synthetic vaccine developer Vaxxinity Inc. traded 23% higher after the company reported it has dosed the first patient in its Phase 1b UB-312 Parkinson's disease study. More >

Newrange Expands Gold Search in 2022
Source: Streetwise Reports  (1/11/22)
Newrange Gold Corp. is expanding its search for precious minerals from one project to three in 2022 and looking at the big picture at its flagship operation in Nevada. More >

Media Co. Gets New Listing on CSE
Source: Streetwise Reports  (1/11/22)
Mijem Newcomm Tech is going public to capitalize on the cryptocurrencies trend, given it now rewards users of its marketplace app with Bitcoin SV. More >

Financial Firm Recommends Royalty and Streaming Cos.
  (1/11/22)
These companies are attractive now because, unlike mining operators, they are insulated from inflationary costs, noted a BMO Capital Markets report. More >

Bitcoin Miner Announces Q4/21 Production, 2022 Outlook
  (1/11/22)
COVID and supply chain constraints hampered its Q4/21 production, but Riot Blockchain is bullish on its 2022 performance, noted a ROTH Capital Partners report. More >

Biotech Co. Partners With Life Sciences Firms
  (1/11/22)
2seventy entered agreements with Novo Nordisk and Genevant to get an in vivo gene editing treatment for hemophilia A developed, noted a Wedbush report. More >

Analyst Stands at Crossroads in 2022
Source: Michael Ballanger  (1/11/22)
With the accelerating involvement of government in the day-to-day behavior of all markets, it's a near-impossibility to forecast what will happen in 2022, Michael Ballanger says. More >

Gold Mining Co. to Trade on TSX.V, Sampling Results Positive
Source: Streetwise Reports  (1/11/22)
Reyna Gold, approved for listing on Toronto's Venture Exchange, finds high-grade gold in samples from La Gloria that highlight the project's potential. More >

HealthCare Solutions Co. Gains 8 Million New Members in 2021
Source: Streetwise Reports  (1/11/22)
Accolade Inc. shares rose 27% after the company reported Q3/22 financial results that included a 117% increase in YoY revenue. The firm highlighted that in calendar year 2021, its membership increased four-fold from 2 million to 10 million. More >

2022 to Be Catalyst Rich for Biopharma
  (1/10/22)
The potential stock-moving events for Infinity Pharmaceuticals this year include the launch of two clinical trials and readouts from four studies, noted an H.C. Wainwright & Co. report. More >

Enrollment Done for COVID-19 Drug Trial
  (1/10/22)
Part 2 of First Wave BioPharma's RESERVOIR trial of niclosamide to remove the SARS-CoV-2 virus from the GI tract is underway, noted a ROTH Capital Partners report. More >

Words With Friends & Grand Theft Auto in Gaming Merger
Source: Streetwise Reports  (1/10/22)
Social gamer Zynga traded 40% higher after the company agreed to be acquired by Take-Two Interactive Inc. in a combination stock and cash transaction for $9.861 per share. More >